Journal of Traditional Chinese Medicine ›› 2023, Vol. 43 ›› Issue (6): 1110-1117.DOI: 10.19852/j.cnki.jtcm.20230404.003
• Research Articles • Previous Articles Next Articles
CHENG Huanbo1,2, HU Hui3,4, SUN Daihua3, WANG Guangzhong4()
Received:
2022-11-11
Accepted:
2023-02-22
Online:
2023-10-25
Published:
2023-04-04
Contact:
WANG Guangzhong, Hubei Engineering Technology Research Center of Chinese Materia Medica Processing, College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China. wgzhong4067@sina.com. Telephone: +86-13597644377
Supported by:
CHENG Huanbo, HU Hui, SUN Daihua, WANG Guangzhong. Anti-inflammatory, anti-tussive effects and toxicity evaluation of Qingfei Dayuan granules (清肺达原颗粒)[J]. Journal of Traditional Chinese Medicine, 2023, 43(6): 1110-1117.
Figure 1 Effects of QFDY on swelling degree and inflammatory cytokines in the xylene-induced ear edema in mice model A: swelling degree; B: TNF-α; C: IL-1β; D: IL-6. SC groups: treated with distilled water; AC groups: treated with 520 mg/kg aspirin; LQ, MQ, and HQ groups were given 3.90, 5.46 and 7.80 g/kg QFDY per day, respectively, each group was administered once a day for 7 d. SC: solvent control group; AC: aspirin control group; LQ: low-dose group; MQ: medium-dose group; HQ: high-dose groups; TNF-α: tumor necrosis factor-α; IL-1β: interleukin-1β; IL-6: interleukin-6. aP < 0.01, bP < 0.05, significantly different compared with SC group; cP < 0.05, significantly different compared with AC group.
Group | n | Dose | Latent period cough (s) | No. of coughs | Inhibition (%) | Cough Activity (%) |
---|---|---|---|---|---|---|
SC | 10 | 0 g/kg | 7.6±1.3 | 41.2±12.7 | - | - |
PC | 10 | 25 mg/kg | 16.5±6.8a | 12.0±3.6b | 70.9 | - |
LQ | 10 | 3.90 g/kg | 12.4±4.9 | 39.1±12.4 | 5.1 | 7.2 |
MQ | 10 | 5.46 g/kg | 13.1±2.8b | 25.4±6.3a | 38.3 | 54.1 |
HQ | 10 | 7.80 g/kg | 18.9±3.7b | 14.1±3.5b | 65.8 | 92.8 |
Table 1 Effects of QFDY on the ammonia liquor induced cough in mice (
Group | n | Dose | Latent period cough (s) | No. of coughs | Inhibition (%) | Cough Activity (%) |
---|---|---|---|---|---|---|
SC | 10 | 0 g/kg | 7.6±1.3 | 41.2±12.7 | - | - |
PC | 10 | 25 mg/kg | 16.5±6.8a | 12.0±3.6b | 70.9 | - |
LQ | 10 | 3.90 g/kg | 12.4±4.9 | 39.1±12.4 | 5.1 | 7.2 |
MQ | 10 | 5.46 g/kg | 13.1±2.8b | 25.4±6.3a | 38.3 | 54.1 |
HQ | 10 | 7.80 g/kg | 18.9±3.7b | 14.1±3.5b | 65.8 | 92.8 |
Figure 2 Effects of sub-chronic toxicity experiment of QFDY on mean body weight and food intake A: body weight in male; B: body weight in female; C: food intake in male; D: food intake in female. SC groups: treated with distilled water; LQ, MQ, and HQ groups were given 4, 8 and 16 g/kg QFDY per day, respectively, each group (n = 30, 15 males and 15 females) was administered once a day for 28 and 30 d of post treatment was conducted. SC: solvent control group, LQ: low-dose group, MQ: medium-dose group, HQ: high-dose groups. aP < 0.05, bP < 0.001, significantly different compared to the SC group.
Parameter | Level | Males | Females | |||||||
---|---|---|---|---|---|---|---|---|---|---|
SC | LQ | MQ | HQ | SC | LQ | MQ | HQ | |||
UBG | - | 10 | 10 | 10 | 7 | 10 | 9 | 10 | 6 | |
± | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
+ | 0 | 0 | 0 | 3 | 0 | 1 | 0 | 4a | ||
BIL | - | 10 | 10 | 8 | 2 | 10 | 8 | 9 | 3 | |
± | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
+ | 0 | 0 | 2 | 8b | 0 | 2 | 1 | 7b | ||
KET | - | 5 | 0 | 0 | 0 | 10 | 8 | 7 | 2 | |
± | 5 | 9 | 7 | 4 | 0 | 2 | 3 | 8b | ||
+ | 0 | 1a | 3a | 6b | 0 | 0 | 0 | 0 | ||
LEU | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
± | 1 | 1 | 0 | 0 | 4 | 0 | 1 | 0 | ||
+ | 8 | 9 | 9 | 5 | 6 | 9 | 7 | 5 | ||
++ | 1 | 0 | 1 | 4 | 0 | 1 | 1 | 5c | ||
+++ | 0 | 0 | 0 | 1a | 0 | 0 | 0 | 0 |
Table 2 Effects of QFDY on urine indexes in end of treatment period (rat numbers)
Parameter | Level | Males | Females | |||||||
---|---|---|---|---|---|---|---|---|---|---|
SC | LQ | MQ | HQ | SC | LQ | MQ | HQ | |||
UBG | - | 10 | 10 | 10 | 7 | 10 | 9 | 10 | 6 | |
± | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
+ | 0 | 0 | 0 | 3 | 0 | 1 | 0 | 4a | ||
BIL | - | 10 | 10 | 8 | 2 | 10 | 8 | 9 | 3 | |
± | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
+ | 0 | 0 | 2 | 8b | 0 | 2 | 1 | 7b | ||
KET | - | 5 | 0 | 0 | 0 | 10 | 8 | 7 | 2 | |
± | 5 | 9 | 7 | 4 | 0 | 2 | 3 | 8b | ||
+ | 0 | 1a | 3a | 6b | 0 | 0 | 0 | 0 | ||
LEU | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
± | 1 | 1 | 0 | 0 | 4 | 0 | 1 | 0 | ||
+ | 8 | 9 | 9 | 5 | 6 | 9 | 7 | 5 | ||
++ | 1 | 0 | 1 | 4 | 0 | 1 | 1 | 5c | ||
+++ | 0 | 0 | 0 | 1a | 0 | 0 | 0 | 0 |
Parameter | Level | Males | Females | |||||||
---|---|---|---|---|---|---|---|---|---|---|
SC | LQ | MQ | HQ | SC | LQ | MQ | HQ | |||
UBG | - | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |
± | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
+ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
BIL | - | 4 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | |
± | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
+ | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||
KET | - | 3 | 2 | 0 | 0 | 5 | 5 | 5 | 5 | |
± | 1 | 3 | 4 | 4 | 0 | 0 | 0 | 0 | ||
+ | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | ||
LEU | - | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
± | 0 | 2 | 1 | 0 | 2 | 3 | 2 | 5 | ||
+ | 5 | 3 | 4 | 5 | 1 | 2 | 3 | 0 | ||
++ | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||
+++ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Table 3 Effects of QFDY granules on urine indexes in end of recovery period (rat numbers)
Parameter | Level | Males | Females | |||||||
---|---|---|---|---|---|---|---|---|---|---|
SC | LQ | MQ | HQ | SC | LQ | MQ | HQ | |||
UBG | - | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |
± | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
+ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
BIL | - | 4 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | |
± | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
+ | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||
KET | - | 3 | 2 | 0 | 0 | 5 | 5 | 5 | 5 | |
± | 1 | 3 | 4 | 4 | 0 | 0 | 0 | 0 | ||
+ | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | ||
LEU | - | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
± | 0 | 2 | 1 | 0 | 2 | 3 | 2 | 5 | ||
+ | 5 | 3 | 4 | 5 | 1 | 2 | 3 | 0 | ||
++ | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||
+++ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Figure 3 Histological findings of SC group and HQ group in the recovery period A: histological findings of SC group in lungs (10 × 40); B: histological findings of HQ group in lungs (10 × 40); C: histological findings of SC group in livers (10 × 20); D: histological findings of HQ group in livers (10 × 20); E: histological findings of SC group in kidneys (10 × 20); F: histological findings of HQ group in kidneys (10 × 10). SC groups: treated with distilled water, HQ groups: given 16 g/kg QFDY per day, each group (n = 30) was administered once a day for 28 and 30 d of post treatment was conducted. All stained with hematoxylin-eosin. SC: solvent control group; HQ: high-dose groups.
1. | Zhu QG, Zhang SP, Li JX, et al. Effectiveness of Liu-zi-jue exercise on coronavirus disease 2019 in the patients: a randomized controlled trial. J Tradit Chin Med 2022; 42: 997-10053. |
2. |
Ren JL, Zhang AH, Wang XJ. Traditional Chinese Medicine for COVID-19 treatment. Pharmacol Res 2020; 155: 104743.
DOI URL |
3. |
Ai ZZ, Zhou S, Li WN, et al. “Fei Yan No. 1” as a combined treatment for COVID-19: an efficacy and potential mechanistic study. Front Pharmacol 2020; 11: 581277.
DOI URL |
4. | Gan DL, Shi JF, Yang SY, Xiang MX. Pharmacological mechanism of Qingfei Dayuan granules for the treatment of pneumonia by network pharmacology. Zhong Guo Yao Ke Da Xue Xue Bao 2020; 51: 568-76. |
5. | Zhou SS, Li WN, Ai ZZ, Wang LQ, Ba YM. Investigating mechanism of Qingfei Dayuan granules for treatment of COVID-19 based on network pharmacology and molecular docking. Zhong Cao Yao 2020; 51: 1804-13. |
6. | Xiang Y, Gao QH, Lyu WL. Study on the potential material basis of Qingfei Dayuan granules in the treatment of coronavirus disease 2019. Shi Jie Zhong Yi Yao 2020; 15: 512-18. |
7. |
Li XJ, Li XY, Huang N, Liu RP, Sun R. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine 2018; 50: 73-87.
DOI PMID |
8. |
Jia XL, Dang SS, Cheng YN, et al. Effects of saikosaponin-d on syndecan-2, matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in rats with hepatocellular carcinoma. J Tradit Chin Med 2012; 32: 415-22.
DOI PMID |
9. |
Yang F, Feng C, Yao YX, Qin AJ, Shao HX. Antiviral effect of baicalin on Marek's disease virus in CEF cells. BMC Vet Res 2020; 16: 371.
DOI PMID |
10. |
Zhu CL, Feng CL, Feng F, et al. Baicalin inhibits inflammation of lipopolysaccharide-induced acute lung injury toll like receptor-4/myeloid differentiation primary response 88/nuclear factor-kappa B signaling pathway. J Tradit Chin Med 2022; 42: 200-12.
DOI PMID |
11. |
Luo J, Dong B, Wang K, et al. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model. PLoS One 2017; 12: e0176883.
DOI URL |
12. |
Kim H, Lim CY, Chung MS. Magnolia officinalis and its honokiol and magnolol constituents inhibit human norovirus surrogates. Foodborne Pathog Dis 2021; 18: 24-30.
DOI URL |
13. | Lou GG, Luo YT, Xie LP, Yao HP, Hu Q. Mechanism of apoptotic induction on T24 cells by honokiol and its synergistic anticancer effect in combination with hydroxycamptothecin. J Tradit Chin Med 2021; 41: 515-22. |
14. |
Tang XQ, Wang YF, Yang WX, et al. Acute and subchronic oral toxicity study of gardenia yellow E 500 in sprague-dawley rats. Int J Environ Res Public Health 2020; 17: 531.
DOI URL |
15. |
Wang DD, Wang S, Chen X, et al. Antitussive, expectorant and anti-inflammatory activities of four alkaloids isolated from Bulbus of Fritillaria wabuensis. J Ethnopharmacol 2012; 139: 189-93.
DOI PMID |
16. |
Wang DD, Zhu JY, Wang S, et al. Antitussive, expectorant and anti-inflammatory alkaloids from Bulbus Fritillariae Cirrhosae. Fitoterapia 2011; 82: 1290-94.
DOI PMID |
17. |
Han N, Chang CL, Wang YC, Huang T, Liu ZH, Yin J. The in vivo expectorant and antitussive activity of extract and fractions from Reineckia carnea. J Ethnopharmacol 2010; 131: 220-3.
DOI PMID |
18. |
Ni LQ, Chen LL, Huang X, et al. Combating COVID-19 with integrated Traditional Chinese and Western Medicine in China. Acta Pharm Sin B 2020; 10: 1149-62.
DOI PMID |
19. |
Lee SS, Yang SF, Tsai CH, et al. Upregulation of heme oxygenase-1 expression in areca-quid-chewing-associated oral squamous cell carcinoma. J Formos Med Assoc 2008; 107: 355-63.
DOI URL |
20. |
Siangproh W, Teshima N, Sakai T, Katoh K, Chailapakul O. Alternative method for measurement of albumin/creatinine ratio using spectrophotometric sequential injection analysis. Talanta 2009; 79: 1111-7.
DOI PMID |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 219
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 180
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Sponsored by China Association of Chinese Medicine
& China Academy of Chinese Medical Sciences
16 Nanxiaojie, Dongzhimen Nei, Beijing, China. 100700 Email: jtcmen@126.com
Copyright 2020 Journal of Traditional Chinese Medicine. All rights reserved.